Angiogenesis and cancer metastases: therapeutic approaches
- 1 August 1995
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 20 (1-2) , 9-39
- https://doi.org/10.1016/1040-8428(94)00142-g
Abstract
No abstract availableThis publication has 231 references indexed in Scilit:
- Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cellsPublished by Elsevier ,2004
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsPublished by Elsevier ,2004
- Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance geneBiochemical and Biophysical Research Communications, 1991
- Laminin surface binding sites and metastatic potential of 3LL tumor cells, increased by indomethacinBiochemical and Biophysical Research Communications, 1990
- Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cellsBiochemical and Biophysical Research Communications, 1988
- Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells invitro: Implications for a role of heparinase-like enzymes in the neovascular responseBiochemical and Biophysical Research Communications, 1987
- Fibronectin-degrading proteases from the membranes of transformed cellsCell, 1987
- Partial purification of a 5.7K glycoprotein from bovine vitreous which inhibits both angiogenesis and collagenase activityBiochemical and Biophysical Research Communications, 1985
- Regulation of type IV collagen degrading enzyme by cortisol during human skin fibroblast growthBiochemical and Biophysical Research Communications, 1985
- Elastin degradation by proteases from cultured human breast cancer cellsBiochemical and Biophysical Research Communications, 1982